Aldeyra Therapeutics, Inc.
(NASDAQ : ALDX)

( )
ALDX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.79%79.141.2%$541.48m
AMGNAmgen Inc.
-0.28%185.991.2%$522.30m
GILDGilead Sciences, Inc.
0.08%71.520.9%$518.25m
BIIBBiogen Inc.
0.16%297.341.2%$439.96m
NKTRNektar Therapeutics
-3.97%55.865.6%$383.38m
SRPTSarepta Therapeutics, Inc.
-2.63%149.6516.6%$325.83m
VRTXVertex Pharmaceuticals Incorporated
-0.67%156.571.9%$253.87m
REGNRegeneron Pharmaceuticals, Inc.
-2.34%329.042.6%$243.76m
ILMNIllumina, Inc.
-0.56%286.053.5%$191.71m
AAgilent Technologies, Inc.
0.40%63.041.5%$180.09m
BLUEBluebird Bio, Inc.
2.32%187.3515.7%$156.91m
ALXNAlexion Pharmaceuticals, Inc.
1.04%125.812.0%$149.34m
EXASExact Sciences Corporation
-0.74%68.8225.5%$144.87m
BMRNBioMarin Pharmaceutical Inc.
0.09%98.434.4%$139.42m
INCYIncyte Corporation
-1.28%72.492.5%$126.38m

Company Profile

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.